Kim et al. [239] reported that galbanic acid (213) reduced the number of blood vessels in tumor cells by more than 40%, significantly reduced the proliferation of vascular endothelial growth factor-(VEGF)-induced human umbilical-vein endothelial cells (HUVECs), and inhibited VEGF-induced migration and tube formation in HUVECs. The gene discussed is VEGFA; the disease is neoplasm.